These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6590568

  • 1. Induction of terminal differentiation in human K562 erythroleukemia cells by arabinofuranosylcytosine.
    Luisi-DeLuca C, Mitchell T, Spriggs D, Kufe DW.
    J Clin Invest; 1984 Sep; 74(3):821-7. PubMed ID: 6590568
    [Abstract] [Full Text] [Related]

  • 2. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
    Watanabe T, Mitchell T, Sariban E, Sabbath K, Griffin J, Kufe D.
    Mol Pharmacol; 1985 Jun; 27(6):683-8. PubMed ID: 3858662
    [Abstract] [Full Text] [Related]

  • 3. Hemoglobin induction by Ara-C in human erythroleukemic cells (K562) is cell-cycle dependent.
    Wanda PE, Walker MM.
    Leuk Res; 1989 Jun; 13(8):683-8. PubMed ID: 2796376
    [Abstract] [Full Text] [Related]

  • 4. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL, Wu RT.
    Cancer Res; 1994 Apr 15; 54(8):2192-8. PubMed ID: 7513611
    [Abstract] [Full Text] [Related]

  • 5. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
    Okabe-Kado J, Hayashi M, Honma Y, Hozumi M.
    Cancer Res; 1986 Mar 15; 46(3):1239-43. PubMed ID: 3455882
    [Abstract] [Full Text] [Related]

  • 6. Cellular and clinical pharmacology of low-dose ara-C.
    Kufe DW, Griffin JD, Spriggs DR.
    Semin Oncol; 1985 Jun 15; 12(2 Suppl 3):200-7. PubMed ID: 3925558
    [Abstract] [Full Text] [Related]

  • 7. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov 15; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S, Bhalla K, Rauscher F, Cadman E.
    Cancer Res; 1983 Nov 15; 43(11):5093-100. PubMed ID: 6577943
    [Abstract] [Full Text] [Related]

  • 10. Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease.
    Bianchi Scarrà GL, Romani M, Coviello DA, Garrè C, Ravazzolo R, Vidali G, Ajmar F.
    Cancer Res; 1986 Dec 15; 46(12 Pt 1):6327-32. PubMed ID: 3536078
    [Abstract] [Full Text] [Related]

  • 11. Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cells.
    Baker SJ, Pawlita M, Leutz A, Hoelzer D.
    Leukemia; 1994 Aug 15; 8(8):1309-17. PubMed ID: 8057666
    [Abstract] [Full Text] [Related]

  • 12. Effect of antimetabolites and thymidine blockage on the induction of differentiation of HL-60 cells by retinoic acid or 1 alpha,25-dihydroxyvitamin D3.
    Ishikura H, Okazaki T, Mochizuki T, Izumi Y, Tashima M, Sawada H, Uchino H.
    Exp Hematol; 1985 Nov 15; 13(10):981-8. PubMed ID: 3932088
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of ara-A on differentiation and proliferation of HL-60 cells.
    Munroe D, Sugiura M, Griffin J, Kufe D.
    Leuk Res; 1984 Nov 15; 8(3):355-61. PubMed ID: 6589455
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction to erythroid differentiation of K562 cells by 1-beta-D-arabinofuranosylcytosine is inhibited by iron chelators: reversion by treatment with hemin.
    Feriotto G, Nastruzzi C, Barbieri R, Gambari R.
    Blut; 1988 Jul 15; 57(1):25-30. PubMed ID: 3164639
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation.
    Toffoli G, Viel A, Bevilacqua C, Maestro R, Tumiotto L, Boiocchi M.
    Leuk Res; 1989 Jul 15; 13(4):279-87. PubMed ID: 2654492
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
    Ferrero D, Tarella C, Gallo E, Ruscetti FW, Breitman TR.
    Cancer Res; 1982 Nov 15; 42(11):4421-6. PubMed ID: 6957259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.